Endoscopic Screening for Gastric Cancer

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 6, 2006, Pages 709-716

  Dan, Yock Young ^a   So, J B Y ^a   Yeoh, Khay Guan ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER SCREENING; CHINESE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEATH; ENDOSCOPIC ECHOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POPULATION MODEL; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; SINGAPORE; STANDARDIZATION; STOMACH CARCINOMA; UNITED STATES;

AGED; COST-BENEFIT ANALYSIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SINGAPORE; STOMACH NEOPLASMS;

EID: 33744718127     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.03.025     Document Type: Article

References (39)

1. Pisani P., Parkin D.M., Bray F., et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83 (1999) 18-29
2. Fukao A., Tsubono Y., Tsuji I., et al. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan. a population-based case-control study. Int J Cancer 60 (1995) 45-48
3. Hisamichi S. Screening for gastric cancer. World J Surg 13 (1989) 31-37
4. Hisamichi S., Sugawara N., and Fukao A. Effectiveness of gastric mass screening in Japan. Cancer Detect Prev 11 (1988) 323-329
5. Kubota H., Kotoh T., Masunaga R., et al. Impact of screening survey of gastric cancer on clinicopathological features and survival. retrospective study at a single institution. Surgery 128 (2000) 41-47
6. Whiting J.L., Sigurdsson A., Rowlands D.C., et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 50 (2002) 378-381
7. Ferlay J., Bray F., and Pisani P. Globocan 2000: cancer incidence, mortality and prevalence worldwide. Volume 2004. IARC CancerBase no 5 (version 1.0) ed (2001), IARC Press, Lyon, France
8. Walker I.R., Strickland R.G., Ungar B., et al. Simple atrophic gastritis and gastric carcinoma. Gut 12 (1971) 906-911
9. Watabe H., Mitsushima T., Yamaji Y., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status. a prospective endoscopic cohort study. Gut 54 (2005) 764-768
10. IARC working group on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes, and Helicobacter pylori. views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans, IARC monographs on the evaluation of carcinogenic risks (1994), International Agency for Research on Cancer, Lyon, France 177-240
11. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276 (1996) 1253-1258
12. Drummond M.F., and Jefferson T.O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. the BMJ economic evaluation working party. BMJ 313 (1996) 275-283
13. Sonnenberg F.A., and Beck J.R. Markov models in medical decision making. a practical guide. Med Decis Making 13 (1993) 322-338
14. Chia H.L., and Shanugaratnam K. Cancer incidence in Singapore 1993-1997 (2000), Singapore Cancer Registry, Singapore
15. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed (2002), Springer, New York 99-106
16. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
17. Dupont Jr. J.B., Lee J.R., Burton G.R., et al. Adenocarcinoma of the stomach. review of 1,497 cases. Cancer 41 (1978) 941-947
18. Hosokawa O., Tsuda S., Kidani E., et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 30 (1998) 669-674
19. Commission on Macroeconomics and Health. Macroeconomics and health. investing in health for economic development-report of the Commission on Macroeconomics and Health-executive summary (2001), World Health Organization, Geneva
20. World Development Indicators database. Volume 2005 (2003), the World Bank Group, Washington, DC
21. Coleman M.P., Esteve J., and Damiecki P. Trends in cancer incidence and mortality (1993), IARC Science Publications, Lyon, France
22. Department of Statistics. Yearbook of statistics, Singapore 2003 (2003), Department of Statistics, Singapore
23. Ti T.K. Pattern and surgical treatment of gastric cancer in Singapore. Br J Surg 80 (1993) 886-889
24. Koong H.N., Chan H.S., Nambiar R., et al. Gastric cancers in Singapore. poor prognosis arising from late presentation. Aust N Z J Surg 66 (1996) 813-815
25. Matsukuma A., Furusawa M., Tomoda H., et al. A clinicopathological study of asymptomatic gastric cancer. Br J Cancer 74 (1996) 1647-1650
26. Fock K.M. Helicobacter pylori infection. current status in Singapore. Ann Acad Med Singapore 26 (1997) 637-641
27. Wong B.C., Lam S.K., Wong W.M., et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. a randomized controlled trial. JAMA 291 (2004) 187-194
28. Robert G., Brown J., and Garvican L. Cost of quality management and information provision for screening. colorectal cancer screening. J Med Screen 7 (2000) 31-34
29. Glimelius B., Hoffman K., Graf W., et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 6 (1995) 267-274
30. Blazeby J.M., Conroy T., Bottomley A., et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer 40 (2004) 2260-2268
31. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 (1988) 3554-3360
32. Hart R., and Classen M. Complications of diagnostic gastrointestinal endoscopy. Endoscopy 22 (1990) 229-233
33. Silvis S.E., Nebel O., Rogers G., et al. Endoscopic complications. results of the 1974 American Society for Gastrointestinal Endoscopy survey. JAMA 235 (1976) 928-930
34. Dekker W., and Tytgat G.N. Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. a follow-up analysis. Gastroenterology 73 (1977) 710-714
35. Kim Y.S., Park H.A., Kim B.S., et al. Efficacy of screening for gastric cancer in a Korean adult population. a case-control study. J Korean Med Sci 15 (2000) 510-515
36. Fujita S. Biology of early gastric carcinoma. Pathol Res Pract 163 (1978) 297-309
37. Rajnakova A.H.K., Tun M., and Yeoh K.G. What is the appropriate endoscopic surveillance interval for patients with helicobacter pylori-associated gastritis and intestinal metaplasia in a country with moderate risk of gastric cancer?. Gastroenterology 126 Suppl 2 (2004) A620 (abstract)
38. Yamazaki H., Oshima A., Murakami R., et al. A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer 63 (1989) 613-617
39. Tsukuma H., Oshima A., Narahara H., et al. Natural history of early gastric cancer. a non-concurrent, long term, follow up study. Gut 47 (2000) 618-621